Lamotrigine Patent Expiration

Lamotrigine was first introduced by Glaxosmithkline Llc in its drug Lamictal on Dec 27, 1994. Other drugs containing Lamotrigine are Lamictal Odt, Lamictal Cd, Lamictal Xr. 40 different companies have introduced drugs containing Lamotrigine.


Lamotrigine Patents

Given below is the list of patents protecting Lamotrigine, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Lamictal Odt US7919115 Orally disintegrating tablet compositions of lamotrigine Jan 04, 2029 Glaxosmithkline Llc
Lamictal Odt US8840925 Orally disintegrating tablet compositions of lamotrigine Jul 02, 2028 Glaxosmithkline Llc
Lamictal Odt US9339504 Orally disintegrating tablet compositions of lamotrigine Jul 02, 2028 Glaxosmithkline Llc
Lamictal Xr US8637512 Formulations and method of treatment Jun 14, 2028 Glaxosmithkline Llc
Lamictal Xr US9144547 Oral dosage form for controlled drug release Sep 22, 2023

(Expired)

Glaxosmithkline Llc
Lamictal Cd US5698226

(Pediatric)

Water-dispersible tablets Jul 29, 2012

(Expired)

Glaxosmithkline Llc



Lamotrigine's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List



Lamotrigine Generics

Several generic applications have been filed for Lamotrigine. The first generic version for Lamotrigine was by Teva Pharmaceuticals Usa Inc and was approved on Jun 21, 2006. And the latest generic version is by Amring Pharmaceuticals Inc and was approved on Feb 3, 2022.

Given below is the list of companies who have filed for Lamotrigine generic.


1. ACTAVIS ELIZABETH

Actavis Elizabeth Llc has filed for 6 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Actavis Elizabeth.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG tablet, extended release Prescription ORAL AB Oct 17, 2013
25MG tablet, extended release Prescription ORAL AB Oct 17, 2013
50MG tablet, extended release Prescription ORAL AB Oct 17, 2013
300MG tablet, extended release Prescription ORAL AB Oct 17, 2013
200MG tablet, extended release Prescription ORAL AB Oct 17, 2013
250MG tablet, extended release Prescription ORAL AB Nov 13, 2013


2. ACTAVIS TOTOWA

Actavis Totowa Llc has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Actavis Totowa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG tablet Discontinued ORAL N/A Apr 8, 2011
25MG tablet Discontinued ORAL N/A Apr 8, 2011
100MG tablet Discontinued ORAL N/A Apr 8, 2011
150MG tablet Discontinued ORAL N/A Apr 8, 2011


3. AJANTA PHARMA LTD

Ajanta Pharma Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Ajanta Pharma Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG tablet, orally disintegrating Prescription ORAL AB Jan 19, 2021
25MG tablet, orally disintegrating Prescription ORAL AB Jan 19, 2021
200MG tablet, orally disintegrating Prescription ORAL AB Jan 19, 2021
100MG tablet, orally disintegrating Prescription ORAL AB Jan 19, 2021


4. ALEMBIC

Alembic Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Alembic.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG tablet, for suspension Prescription ORAL AB Jun 12, 2014
5MG tablet, for suspension Prescription ORAL AB Jun 12, 2014


5. ALEMBIC PHARMS LTD

Alembic Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Alembic Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG tablet Prescription ORAL AB Jan 13, 2011
100MG tablet Prescription ORAL AB Jan 13, 2011
150MG tablet Prescription ORAL AB Jan 13, 2011
200MG tablet Prescription ORAL AB Jan 13, 2011


6. ALKEM LABS LTD

Alkem Laboratories Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Alkem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG tablet Prescription ORAL AB Jun 14, 2013
200MG tablet Prescription ORAL AB Jun 14, 2013
150MG tablet Prescription ORAL AB Jun 14, 2013
100MG tablet Prescription ORAL AB Jun 14, 2013


7. AMNEAL PHARMS

Amneal Pharmaceuticals Of New York Llc has filed for 6 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Amneal Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG tablet, extended release Prescription ORAL AB Nov 30, 2018
50MG tablet, extended release Prescription ORAL AB Nov 30, 2018
200MG tablet, extended release Prescription ORAL AB Nov 30, 2018
100MG tablet, extended release Prescription ORAL AB Nov 30, 2018
300MG tablet, extended release Prescription ORAL AB Nov 30, 2018
250MG tablet, extended release Prescription ORAL AB Nov 30, 2018


8. AMRING PHARMS

Amring Pharmaceuticals Inc has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Amring Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG tablet, orally disintegrating Prescription ORAL AB Feb 3, 2022
25MG tablet, orally disintegrating Prescription ORAL AB Feb 3, 2022
50MG tablet, orally disintegrating Prescription ORAL AB Feb 3, 2022
200MG tablet, orally disintegrating Prescription ORAL AB Feb 3, 2022


9. AUROBINDO PHARMA

Aurobindo Pharma Ltd has filed for 5 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG tablet, for suspension Prescription ORAL AB Nov 4, 2009
100MG tablet Prescription ORAL AB Jan 27, 2009
150MG tablet Prescription ORAL AB Jan 27, 2009
200MG tablet Prescription ORAL AB Jan 27, 2009
5MG tablet, for suspension Prescription ORAL AB Nov 4, 2009


10. CHARTWELL MOLECULAR

Chartwell Molecular Holdings Llc has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Chartwell Molecular.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG tablet Discontinued ORAL N/A Nov 1, 2010
100MG tablet Discontinued ORAL N/A Nov 1, 2010
25MG tablet Discontinued ORAL N/A Nov 1, 2010
200MG tablet Discontinued ORAL N/A Nov 1, 2010


11. DR REDDYS LABS LTD

Dr Reddys Laboratories Ltd has filed for 8 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Dr Reddys Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG tablet, extended release Prescription ORAL AB Jun 19, 2013
5MG tablet, for suspension Prescription ORAL AB Jan 22, 2009
100MG tablet, extended release Prescription ORAL AB Jun 19, 2013
150MG tablet Prescription ORAL AB Jan 27, 2009
200MG tablet, extended release Prescription ORAL AB Jun 19, 2013
50MG tablet, extended release Prescription ORAL AB Jun 19, 2013
300MG tablet, extended release Prescription ORAL AB Jun 19, 2013
250MG tablet, extended release Prescription ORAL AB Sep 6, 2018


12. ENDO OPERATIONS

Endo Operations Ltd has filed for 6 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Endo Operations.

Strength Dosage Form Availability Application Pathway TE code Launch Date
300MG tablet, extended release Prescription ORAL AB Jan 18, 2013
250MG tablet, extended release Prescription ORAL AB Jan 18, 2013
200MG tablet, orally disintegrating Prescription ORAL AB Oct 27, 2015
100MG tablet, orally disintegrating Prescription ORAL AB Oct 27, 2015
50MG tablet, orally disintegrating Prescription ORAL AB Oct 27, 2015
25MG tablet, orally disintegrating Prescription ORAL AB Oct 27, 2015


13. GLENMARK PHARMS LTD

Glenmark Pharmaceuticals Ltd has filed for 5 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Glenmark Pharms Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG tablet Prescription ORAL AB May 4, 2012
5MG tablet, for suspension Prescription ORAL AB Feb 19, 2009
150MG tablet Prescription ORAL AB May 4, 2012
100MG tablet Prescription ORAL AB May 4, 2012
200MG tablet Prescription ORAL AB May 4, 2012


14. GRANULES

Granules India Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Granules.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG tablet Discontinued ORAL N/A Jan 27, 2009
100MG tablet Discontinued ORAL N/A Jan 27, 2009
150MG tablet Discontinued ORAL N/A Jan 27, 2009
200MG tablet Discontinued ORAL N/A Jan 27, 2009


15. HIKMA PHARMS

Hikma Pharmaceuticals has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Hikma Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG tablet Discontinued ORAL N/A Apr 19, 2011
150MG tablet Discontinued ORAL N/A Apr 19, 2011
100MG tablet Discontinued ORAL N/A Apr 19, 2011
200MG tablet Discontinued ORAL N/A Apr 19, 2011


16. IMPAX LABS INC

Impax Laboratories Inc has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Impax Labs Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG tablet, orally disintegrating Discontinued ORAL N/A Jul 15, 2013
25MG tablet, orally disintegrating Discontinued ORAL N/A Jul 15, 2013
50MG tablet, orally disintegrating Discontinued ORAL N/A Jul 15, 2013
200MG tablet, orally disintegrating Discontinued ORAL N/A Jul 15, 2013


17. JUBILANT CADISTA

Jubilant Cadista Pharmaceuticals Inc has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Jubilant Cadista.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG tablet Prescription ORAL AB Jan 27, 2009
100MG tablet Prescription ORAL AB Jan 27, 2009
150MG tablet Prescription ORAL AB Jan 27, 2009
200MG tablet Prescription ORAL AB Jan 27, 2009


18. JUBILANT GENERICS

Jubilant Generics Ltd has filed for 2 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Jubilant Generics.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG tablet, for suspension Discontinued ORAL N/A Feb 28, 2011
25MG tablet, for suspension Discontinued ORAL N/A Feb 28, 2011


19. LUPIN LTD

Lupin Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Lupin Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG tablet Prescription ORAL AB Jun 1, 2010
200MG tablet Prescription ORAL AB Jun 1, 2010
25MG tablet Prescription ORAL AB Jun 1, 2010
150MG tablet Prescription ORAL AB Jun 1, 2010


20. NATCO PHARMA

Natco Pharma Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Natco Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG tablet Discontinued ORAL N/A Jan 27, 2009
100MG tablet Discontinued ORAL N/A Jan 27, 2009
150MG tablet Discontinued ORAL N/A Jan 27, 2009
200MG tablet Discontinued ORAL N/A Jan 27, 2009


21. NORVIUM BIOSCIENCE

Norvium Bioscience Llc has filed for 5 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Norvium Bioscience.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG tablet, for suspension Discontinued ORAL N/A Jan 22, 2009
25MG tablet Discontinued ORAL N/A Feb 11, 2009
200MG tablet Discontinued ORAL N/A Feb 11, 2009
150MG tablet Discontinued ORAL N/A Feb 11, 2009
100MG tablet Discontinued ORAL N/A Feb 11, 2009


22. RISING

Rising Pharma Holding Inc has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Rising.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG tablet Discontinued ORAL N/A Jan 27, 2009
100MG tablet Discontinued ORAL N/A Jan 27, 2009
150MG tablet Discontinued ORAL N/A Jan 27, 2009
200MG tablet Discontinued ORAL N/A Jan 27, 2009


23. ROXANE

Roxane Laboratories Inc has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Roxane.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG tablet Discontinued ORAL N/A Jan 27, 2009
100MG tablet Discontinued ORAL N/A Jan 27, 2009
150MG tablet Discontinued ORAL N/A Jan 27, 2009
200MG tablet Discontinued ORAL N/A Jan 27, 2009


24. RUBICON

Rubicon Research Private Ltd has filed for 5 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Rubicon.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG tablet, extended release Prescription ORAL AB Jun 17, 2013
25MG tablet, extended release Discontinued ORAL N/A Jun 17, 2013
150MG tablet Prescription ORAL AB Jan 27, 2009
200MG tablet, extended release Prescription ORAL AB Jun 17, 2013
50MG tablet, extended release Discontinued ORAL N/A Jun 17, 2013


25. SANDOZ

Sandoz Inc has filed for 5 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG tablet Discontinued ORAL N/A Jan 27, 2009
5MG tablet, for suspension Discontinued ORAL N/A Jan 22, 2009
100MG tablet Discontinued ORAL N/A Jan 27, 2009
150MG tablet Discontinued ORAL N/A Jan 27, 2009
200MG tablet Discontinued ORAL N/A Jan 27, 2009


26. SCIEGEN PHARMS INC

Sciegen Pharmaceuticals Inc has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Sciegen Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG tablet, orally disintegrating Prescription ORAL AB Jun 17, 2016
25MG tablet, orally disintegrating Prescription ORAL AB Jun 17, 2016
50MG tablet, orally disintegrating Prescription ORAL AB Jun 17, 2016
100MG tablet, orally disintegrating Prescription ORAL AB Jun 17, 2016


27. TARO

Taro Pharmaceutical Industries Ltd has filed for 2 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Taro.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG tablet, for suspension Prescription ORAL AB Feb 4, 2009
5MG tablet, for suspension Prescription ORAL AB Feb 4, 2009


28. TARO PHARM INDS

Taro Pharmaceutical Industries Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Taro Pharm Inds.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG tablet Prescription ORAL AB Jan 27, 2009
100MG tablet Prescription ORAL AB Jan 27, 2009
150MG tablet Prescription ORAL AB Jan 27, 2009
200MG tablet Prescription ORAL AB Jan 27, 2009


29. TEVA

Teva Pharmaceuticals Usa Inc has filed for 5 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Teva.

Strength Dosage Form Availability Application Pathway TE code Launch Date
5MG tablet, for suspension Discontinued ORAL N/A Jun 21, 2006
25MG tablet Discontinued ORAL N/A Aug 30, 2006
150MG tablet Discontinued ORAL N/A Aug 30, 2006
200MG tablet Discontinued ORAL N/A Aug 30, 2006
100MG tablet Discontinued ORAL N/A Aug 30, 2006


30. TORRENT

Torrent Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Torrent.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG tablet, extended release Prescription ORAL AB Dec 23, 2013
100MG tablet, extended release Prescription ORAL AB Dec 23, 2013
25MG tablet, extended release Prescription ORAL AB Dec 23, 2013
200MG tablet, extended release Discontinued ORAL N/A Dec 23, 2013


31. TORRENT PHARMS

Torrent Pharmaceuticals Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Torrent Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG tablet Prescription ORAL AB Jan 27, 2009
100MG tablet Prescription ORAL AB Jan 27, 2009
150MG tablet Prescription ORAL AB Jan 27, 2009
200MG tablet Prescription ORAL AB Jan 27, 2009


32. UNICHEM LABS LTD

Unichem Laboratories Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Unichem Labs Ltd.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG tablet Prescription ORAL AB Oct 6, 2011
25MG tablet Prescription ORAL AB Oct 6, 2011
100MG tablet Prescription ORAL AB Oct 6, 2011
150MG tablet Prescription ORAL AB Oct 6, 2011


33. WATSON LABS

Watson Laboratories Inc has filed for 3 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Watson Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG tablet, for suspension Prescription ORAL AB Jan 22, 2009
5MG tablet, for suspension Prescription ORAL AB Jan 22, 2009
2MG tablet, for suspension Prescription ORAL AB Jan 22, 2009


34. WOCKHARDT BIO AG

Wockhardt Bio Ag has filed for 5 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Wockhardt Bio Ag.

Strength Dosage Form Availability Application Pathway TE code Launch Date
50MG tablet, extended release Prescription ORAL AB Jan 4, 2013
300MG tablet, extended release Prescription ORAL AB Jan 4, 2013
200MG tablet, extended release Prescription ORAL AB Jan 4, 2013
100MG tablet, extended release Prescription ORAL AB Jan 4, 2013
25MG tablet, extended release Prescription ORAL AB Jan 4, 2013


35. YILING

Yiling Pharmaceutical Ltd has filed for 6 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Yiling.

Strength Dosage Form Availability Application Pathway TE code Launch Date
250MG tablet, extended release Prescription ORAL AB Dec 8, 2021
100MG tablet, extended release Prescription ORAL AB Dec 8, 2021
50MG tablet, extended release Prescription ORAL AB Dec 8, 2021
25MG tablet, extended release Prescription ORAL AB Dec 8, 2021
300MG tablet, extended release Prescription ORAL AB Dec 8, 2021
200MG tablet, extended release Prescription ORAL AB Dec 8, 2021


36. ZENNOVA

Zennova Pharmaceuticals Chengdu Co Ltd has filed for 4 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Zennova.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100MG tablet Discontinued ORAL N/A Feb 4, 2009
25MG tablet Discontinued ORAL N/A Feb 4, 2009
200MG tablet Discontinued ORAL N/A Feb 4, 2009
150MG tablet Discontinued ORAL N/A Feb 4, 2009


37. ZYDUS PHARMS

Zydus Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Zydus Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
200MG tablet, extended release Prescription ORAL AB Apr 1, 2020
100MG tablet, extended release Prescription ORAL AB Apr 1, 2020
50MG tablet, extended release Prescription ORAL AB Apr 1, 2020
25MG tablet, extended release Prescription ORAL AB Apr 1, 2020
300MG tablet, extended release Prescription ORAL AB Apr 1, 2020
250MG tablet, extended release Prescription ORAL AB Apr 1, 2020


38. ZYDUS PHARMS USA

Zydus Pharmaceuticals Usa Inc has filed for 6 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG tablet Prescription ORAL AB Jan 27, 2009
50MG tablet Prescription ORAL N/A Jan 27, 2009
100MG tablet Prescription ORAL AB Jan 27, 2009
150MG tablet Prescription ORAL AB Jan 27, 2009
200MG tablet Prescription ORAL AB Jan 27, 2009
250MG tablet Prescription ORAL N/A Jan 27, 2009


39. ZYDUS PHARMS USA INC

Zydus Pharmaceuticals Usa Inc has filed for 2 different strengths of generic version for Lamotrigine. Given below are the details of the strengths of this generic introduced by Zydus Pharms Usa Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
25MG tablet, for suspension Prescription ORAL AB Jan 22, 2009
5MG tablet, for suspension Prescription ORAL AB Jan 22, 2009